Issued Patents All Time
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12358920 | Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors | Federica Sotgia, Jussi J. Kangasmetsa, Luma G. Magalhães | 2025-07-15 |
| 12319690 | Selective CDK 4/6 inhibitor cancer therapeutics | Federica Sotgia, Jussi J. Kangasmetsa, Luma G. Magalhães | 2025-06-03 |
| 12208111 | Azithromycin and roxithromycin derivtives as senolytic drugs | Federica Sotgia | 2025-01-28 |
| 12188936 | Biomarkers and therapeutics for endocrine therapy resistance | Federica Sotgia, Marco FIORILLO | 2025-01-07 |
| 12006553 | Companion diagnostics for mitochondrial inhibitors | Federica Sotgia | 2024-06-11 |
| 11964983 | Selective CDK4/6 inhibitor cancer therapeutics | Federica Sotgia, Jussi J. Kangasmetsa | 2024-04-23 |
| 11957700 | Azithromycin and roxithromycin derivatives as senolytic drugs | Federica Sotgia | 2024-04-16 |
| 11918597 | Triple combination therapies for anti-aging | Federica Sotgia | 2024-03-05 |
| 11865130 | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells | Federica Sotgia | 2024-01-09 |
| 11865124 | Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCS) | Federica Sotgia | 2024-01-09 |
| 11738034 | Triphenylphosphonium-derivative compounds for eradicating cancer stem cells | Federica Sotgia | 2023-08-29 |
| 11672810 | Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer | Federica Sotgia | 2023-06-13 |
| 11667639 | Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells | Federica Sotgia | 2023-06-06 |
| 11667640 | Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells | Federica Sotgia | 2023-06-06 |
| 11561227 | Anti-mitochondrial inhibitors for oncogenic Ras and Myc | Federica Sotgia | 2023-01-24 |
| 11559527 | Targeting mitochondrial fission through mDIVI-1 derivatives | Federica Sotgia | 2023-01-24 |
| 11547679 | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast | Federica Sotgia | 2023-01-10 |
| 11497749 | Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (CSCS) by inhibiting mitochondrial respiration | Federica Sotgia | 2022-11-15 |
| 11497759 | Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells | Federica Sotgia | 2022-11-15 |
| 11441195 | Energetic cancer stem cells (e-CSCs): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy | Federica Sotgia, Marco FIORILLO | 2022-09-13 |
| 11364210 | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast | Federica Sotgia | 2022-06-21 |
| 11311501 | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast | Federica Sotgia | 2022-04-26 |
| 11229657 | Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy | Federica Sotgia | 2022-01-25 |
| 11197872 | Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs) | Federica Sotgia | 2021-12-14 |
| 11160821 | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells | Federica Sotgia | 2021-11-02 |